The Acting Administrator of the Drug Enforcement Administration issued an order to extend the temporary schedule I status of ethyl 2-(1-(5- fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other name: 5F-EDMB-PINACA); methyl 2-(1-(5-fluoropentyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate (Other name: 5F-MDMB-PICA); N- (adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: FUB-AKB48, FUB-APINACA, AKB48, N-(4-fluorobenzyl)); 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- 3-carboxamide (Others names: 5F-CUMYL-PINACA; SGT-25); and (1-(4- fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (Other name: FUB-144), and their optical, positional, and geometric isomers, salts, and salts of isomers. This order will extend the temporary scheduling of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL- PINACA and FUB-144 for one year or until the permanent scheduling action for these substances is completed, whichever occurs first. This order was published in the March 31, 2021 issue of the Federal Register, Volume 86, Number 60, pages 16669-16670 and was effective April 16, 2021. The Acting Administrator of the Drug Enforcement Administration issued a final rule removing samidorphan (3-carboxamido-4-hydroxy naltrexone) and its salts from the schedules of the Controlled Substances Act. This final rule was published in the April 19, 2021 issue of the Federal Register, Volume 86, Number 73, pages 20284-20286 and was effective April 19, 2021. This action was based upon the following: 1. Samidorphan does not possess abuse or dependence potential, 2. Samidorphan does not meet the requirements for inclusion in any Schedule. The Drug Enforcement Administration issued a final rule placing ten fentanyl related substances β-methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl)propionamide); β’-phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other name: 3- phenylpropanoyl fentanyl); 2'-fluoro o-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (Other name: 2'-fluoro 2-fluorofentanyl); 4'-methyl acetyl fentanyl (N-(1-(4- methylphenethyl)piperidin-4-yl)-N-phenylacetamide); o-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (Other name: 2-fluorobutyryl fentanyl); o-methyl acetylfentanyl (N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (Other name: 2- methylacetylfentanyl); o-methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (Other name: 2-methyl methoxyacetyl fentanyl); p-methylfentanyl (N-(4-methylphenyl)- N-(1-phenethylpiperidin-4-yl)propionamide (Other name: 4-methylfentanyl); phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (Other name: benzoyl fentanyl); thiofuranyl fentanyl (N-(1-phenethylpiperidin-4- yl)-N-phenylthiophene-2-carboxamide (Other names: 2-thiofuranyl fentanyl, thiophene fentanyl) including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible permanently in schedule I of the Controlled Substances Act. It makes permanent the current scheduling status. This order was published in the April 27, 2021 issue of the Federal Register, Volume 86, Number 79, pages 22113-22118 and was effective April 27, 2021. The Drug Enforcement Administration issued a final order placing the four fentanyl related substances fentanyl carbamate (ethyl (1-phenethylpiperidin- 4-yl)(phenyl)carbamate); o-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide); o-fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); and p-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2- carboxamide), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible permanently into schedule I of the Controlled Substances Act. The order was published in the May 4, 2021 issue of the Federal Register, Volume 86, Number 84, pages 23602-23606 and was effective May 4, 2021. The Drug Enforcement Administration issued an interim final rule placing serdexmethylphenidate, including its salts, isomers, and salts of isomers, in schedule IV of the Controlled Substances Act. This interim final rule was published in the May 7, 2021 issue of the Federal Register, Volume 86, Number 87, pages 24487-24492. The effective date was May 7, 2021. This action was based on the following: 1. Serdexmethylphenidate produces effects that are similar to other stimulants drugs in schedule IV such as phentermine; 2. Serdexmethylphenidate has an accepted medical use in the United States. Pursuant to Section 481.034(g), as amended by the 75th legislature, of the Texas Controlled Substances Act, Health and Safety Code, Chapter 481, at least thirty-one days have expired since notice of the above referenced actions were published in the Federal Register. In the capacity as Commissioner of the Texas Department of State Health Services, John Hellerstedt, M.D., does hereby order the following: Placement of the substances β-methyl fentanyl; β’-phenyl fentanyl; 2'-fluoro o-fluorofentanyl; 4'-methyl acetyl fentanyl; o-fluorobutyryl fentanyl; o- methyl acetylfentanyl; o-methyl methoxyacetyl fentanyl; p-methylfentanyl; phenyl fentanyl; thiofuranyl fentanyl; fentanyl carbamate; o-fluoroacryl; o- fluoroisobutyryl fentanyl; and p-fluoro furanyl fentanyl into schedule I; Extension of the temporary scheduling of the substances 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144; Removal of samidorphan from schedule II; and, Addition of serdexmethylphenidate to schedule IV. -Schedule I opiates The following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts are possible within the specific chemical designation: (1) Acetyl-α-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (Other name: acryloylfentanyl); (5) AH-7921 (3,4-dichloro-N-[1-(dimethylamino) cyclohexymethyl]benzamide); (6) Allylprodine; (7) Alphacetylmethadol (except levo-α-cetylmethadol, levo-α- acetylmethadol, levomethadyl acetate, or LAAM); (8) α-Methylfentanyl or any other derivative of fentanyl; (9) α-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl] N- phenylpropanamide); (10) Benzethidine; (11) β-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide); (12) β-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl- 4-piperidinyl]-N-phenylpropanamide); (13) β-Hydroxythiofentanyl (Other names: N-[1-[2-hydroxy-2-(thiophen-2- yl)ethyl]piperidin-4-yl]-N-phenylproprionamide; N-[1-[2-hydroxy-2-(2- thienyl)ethyl]-4-piperidnyl]-N-phenylpropanamide); *(14) β-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4- yl)propionamide; *(15) β'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide (Other name: 3-phenylpropanoyl fentanyl); (16) Betaprodine; (17) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide); (18) Clonitazene; (19) Crotonyl fentanyl (Other name: (6-2-5) (E)-N-(1-Phenethylpiperidin-4- yl)-N-phenylbut-2-enamide); (20) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- Phenylcyclopentanecarboxamide; (21) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide); (22) Diampromide; (23) Diethylthiambutene; (24) Difenoxin; (25) Dimenoxadol; (26) Dimethylthiambutene; (27) Dioxaphetyl butyrate; (28) Dipipanone; (29) Ethylmethylthiambutene; (30) Etonitazene; (31) Etoxeridine; *(32) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate); *(33) p-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) (Other name: 4-Fluoroisobutyryl fentanyl); *(34) 2'-Fluoro o-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N- (2-fluorophenyl)propionamide (Other name: 2'-fluoro 2-fluorofentanyl); (35) Furanyl fentanyl (N-(1-phenethylpiperdin-4-yl)-N-phenylfuran-2- carboxamide); (36) Furethidine; (37) Hydroxypethidine; (38) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylisobutyramide; (39) Ketobemidone; (40) Levophenacylmorphan; (41) Meprodine; (42) Methadol; (43) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide); *(44) 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N- phenylacetamide; (45) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N- phenylpropanamide); (46) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide); (47) Moramide; (48) Morpheridine; (49) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); (50) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); (51) Noracymethadol; (52) Norlevorphanol; (53) Normethadone; (54) Norpipanone; (55) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4- yl)acetamide); *(56) o-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)acrylamide); *(57) o-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin- 4-yl)butyramide (Other name:2-fluorobutyryl fentanyl); (58) o-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-